Biote (BTMD) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


BTMD Biote Corp BTMD
70 GF Score
Price $1.95
GF Value $3.07
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Biote Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Biote's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BTMD vs DCGO, PIII, PARK: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Care Facilities subindustry, Biote's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biote Margin of Safety % (DCF Earnings Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Biote's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Biote's Margin of Safety % (DCF Earnings Based) falls into.


BTMD
70GF Score
Biote Corp BTMD
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biote (BTMD) Overvalued in 2026?

Based on GuruFocus' analysis, Biote stock appears to be undervalued. The current stock price of $1.95 is trading 36.5% below its estimated GF Value™ of $3.07. GuruFocus considers Biote to be Significantly Undervalued.

Key valuation signals for BTMD:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $3.07 vs. price of $1.95 (36.5% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the BTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biote Business Description

Address 1875 W. Walnut Hill Lane, Suite 100, Irving, TX, USA, 75038
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
70GF Score

Get the complete analysis for BTMD

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price
$3.07
GF Value